Myasthenia gravis after allogeneic bone marrow transplantation: A case report and literature review

Atassi, 2008, Muscle-specific kinase (MuSK) antibody-associated myasthenia gravis after bone marrow transplantation, Muscle Nerve, 38, 1074, 10.1002/mus.21023

Mackey, 1997, Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature, Bone Marrow Transpl, 19, 939, 10.1038/sj.bmt.1700759

Baron, 1998, Myasthenia gravis without chronic GVHD after allogeneic bone marrow transplantation, Bone Marrow Transpl, 2, 197, 10.1038/sj.bmt.1701297

Dowell, 1999, Myasthenia gravis after allogeneic bone marrow transplantation for lymphoblastic lymphoma, Bone Marrow Transpl, 24, 1359, 10.1038/sj.bmt.1702067

Kotani, 2002, Myasthenia gravis after allogeneic bone marrow transplantation treated with mycophenolate mofetil monitored by peripheral blood OX40+CD4+T cells, Eur J Haematol, 69, 318, 10.1034/j.1600-0609.2002.02789.x

Tse, 1999, Myasthenia gravis and polymyositis as manifestation of chronic graft-versus-host disease, Bone Marrow Transpl, 23, 397, 10.1038/sj.bmt.1701575

Adams, 1995, Neuromuscular complications of bone marrow transplantation, Pediat Neurol, 12, 58, 10.1016/0887-8994(94)00097-L

Shimoda, 1994, Myasthenia gravis after allogeneic bone marrow transplantation, Bone Marrow Transpl, 14, 155

Haslam, 1993, Immune complex glomerunephritis, myasthenia gravis and compensated hypothyroidism in a patient following allogeneic bone marrow transplantation, Nephrol Dial Transpl, 8, 1390

Melms, 1992, Myasthenia gravis after BMT: identification of patients at risk?, Bone Marrow Transpl, 9, 78

Grau, 1990, Myasthenia gravis after allogeneic bone marrow transplantation: report of a new case and pathogenetic considerations, Bone Marrow Transpl, 5, 435

Unal, 2014, Successful treatment of severe myasthenia gravis developed after allogeneic hematopoietic stem cell transplantation with plasma exchange and rituximab, Pediatr Blood Cancer, 61, 928, 10.1002/pbc.24799

Heidarzadeh, 2014, Muscle-specific kinase antibody associated myasthenia gravis after bone marrow transplantation, Neuromuscul Disord, 24, 148, 10.1016/j.nmd.2013.11.005

Meriggioli, 2009, Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity, Lancet Neurol, 8, 475, 10.1016/S1474-4422(09)70063-8

Smith, 1989, Auto antibody formation after bone marrow transplantation. Comparison between acetylcholine receptor antibodies and other autoantibodies and analysis of HLA and Gm markers, Eur Neurol, 29, 128, 10.1159/000116395

Teshima, 2008, Chronic graft-versus-host disease: how can we release Prometheus?, Biol Blood Marrow Transpl, 14, 142, 10.1016/j.bbmt.2007.10.023

Mikos, 2004, Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors, Blood, 103, 353, 10.1182/blood-2003-03-0984

Mikos, 2005, Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission, Blood, 105, 2973, 10.1182/blood-2004-09-3660

Zorn, 2004, Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation, J Exp Med, 199, 1133, 10.1084/jem.20031560

Grauer, 2010, Neurological manifestation of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the consensus conference on clinical practice in chronic graft-versus-host disease, Brain, 133, 2852, 10.1093/brain/awq245